the Lundbeck Foundation holds 57.36% of the shares and is thus Falck's largest and controlling shareholder. The Lundbeck Foundation is a Danish-based commercial foundation striving to significantly improve people’s health and wellbeing by: supporting independent Danish research at the highest level, primarily within biomedicine and the natural sciences, and promoting the international scope of the research creating shareholder value within the Lundbeck Group and other internationally renowned companies – now including Falck – and helping them become world leaders in their respective fields. The Lundbeck Foundation was founded in 1954 by Grete Lundbeck, widow of Hans Lundbeck, the founder of the pharmaceutical company H. Lundbeck in 1915. In 2012, the Lundbeck Foundation granted 482 million Danish kroner (more
Nature of Business
Year of Establishment
GST Number
Legal Status of Firm